Biology Reference
In-Depth Information
Anstey, N.M., et al., 2007. Lung injury in vivax malaria: pathophysiological evidence for
pulmonary vascular sequestration and posttreatment alveolar-capillary inflammation.
J. Infect. Dis. 195 (4), 589-596.
Anstey, N.M., et al., 2009. The pathophysiology of vivax malaria. Trends Parasitol. 25,
220-227.
Anstey, N.M., Price, R.N., 2007. Improving case definitions for severe malaria. PLoS Med.
4 (8), e267.
Antia, R.,Yates, A., de Roode, J.C., 2008. The dynamics of acute malaria infections. I. Effect
of the parasite's red blood cell preference. Proc. Biol. Sci. 275 (1641), 1449-1458.
Arora, R.C., et al., 1988. Cerebral malaria caused by Plasmodium vivax . J. Assoc. Physicians
India 36, 564.
Baird, J.K., Surjadjaja, C., 2010. Consideration of ethics in primaquine therapy against
malaria transmission. Trends Parasitol..
Baird, J.K., 2007. Neglect of Plasmodium vivax malaria. Trends Parasitol. 23 (11), 533-539.
Baird, J.K., 2009. Severe and fatal vivax malaria challenges 'benign tertian malaria' dogma.
Ann. Trop. Paediatr. 29, 251-252.
Barber, B.E., William, T., Grigg, M.J., Menon, J., Auburn, S., Marfurt, J., Anstey, N.M.,
Yeo, T.W., 2012. A prospective comparative study of knowlesi, falciparum and vivax
malaria in Sabah, Malaysia: high proportion with severe disease from Plasmodium
knowlesi and P. vivax but no mortality with early referral and artesunate therapy.
Clin. Infect. Dis. doi: 10.1093/cid/cis902.
Barcus, M.J., et al., 2007. Demographic risk factors for severe and fatal vivax and falciparum
malaria among hospital admissions in northeastern Indonesian Papua. Am. J. Trop. Med.
Hyg. 77 (5), 984-991.
Bassat, Q., Alonso, P.L., 2011. Defying malaria: fathoming severe Plasmodium vivax disease.
Nat. Med. 17 (1), 48-49.
Beare, N.A., et al., 2006. Malarial retinopathy: a newly established diagnostic sign in severe
malaria. Am. J. Trop. Med. Hyg. 75 (5), 790-797.
Beg, M., et al., 2002. Cerebral involvement in benign tertian malaria. Am. J. Trop. Med. Hyg.
67, 230-232.
Bejon, P., et al., 2007. Defining childhood severe falciparum malaria for intervention studies.
PLoS Med. 4 (8), e251.
Berkley, J., et al., 1999. Bacteraemia complicating severe malaria in children. Trans. R Soc.
Trop. Med. Hyg. 93, 283-286.
Berkley, J.A., et al., 2009. HIV infection, malnutrition, and invasive bacterial infection among
children with severe malaria. Clin. Infect. Dis. 49 (3), 336-343.
Bhattacharya, J., Swarup-Mitra, S., 1987. Reduction in erythrocytic GSH level and stability
in Plasmodium vivax malaria. Trans. R Soc. Trop. Med. Hyg. 81 (1), 64-66.
Billings, F., Post, W., 1915. Fatal malaria due to the tertian parasite. Trans. Chicago Path Soc.
9, 209-215.
Bircan, Z., et al., 1997. Two cases of nephrotic syndrome and tertian malaria in south-eastern
Anatolia. Pediatr. Nephrol. 11 (1), 78-79.
Biswas, J., et al., 1996. Ocular malaria. A clinical and histopathologic study. Ophthalmology
103 (9), 1471-1475.
Bloland, P.B., et al., 1999. Longitudinal cohort study of the epidemiology of malaria infec-
tions in an area of intense malaria transmission II. Descriptive epidemiology of malaria
infection and disease among children. Am. J. Trop. Med. Hyg. 60 (4), 641-648.
Boshes, B., 1947. Neuropyschiatric manifestations during the course of malaria. Arch. Neu-
rol. Pyschiatr. 58, 14-27.
Boutlis, C.S., et al., 2005. Glycosylphosphatidylinositols in malaria pathogenesis and immu-
nity: potential for therapeutic inhibition and vaccination. Curr. Top. Microbiol. Immu-
nol. 297, 145-185.
Search WWH ::




Custom Search